Skip to main navigation Skip to search Skip to main content

Ethical issues in dementia drug development: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

  • Stephen G. Post
  • , Bjorn Beerman
  • , Henry Brodaty
  • , Atwood W. Gaines
  • , Serge G. Gauthier
  • , David S. Geldmacher
  • , Suzanne Hill
  • , Akira Homma
  • , Martin N. Rossor
  • , Peter J. Whitehouse
  • , Bengt Winblad
  • Medical Drugs Agency
  • Prince Henry Hospital
  • Case Western Reserve University
  • McGill University
  • Therapeutic Goods Administration
  • Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology
  • University College London Hospitals NHS Foundation Trust
  • Karolinska Institutet

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)26-28
Number of pages3
JournalAlzheimer Disease and Associated Disorders
Volume11
Issue numberSUPPL. 3
StatePublished - 1997

Fingerprint

Dive into the research topics of 'Ethical issues in dementia drug development: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines'. Together they form a unique fingerprint.

Cite this